Mediolanum International Funds’s Vertex Pharmaceuticals VRTX Stock Holding History

Mediolanum International Funds’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.89M	Buy	5,776 +71	+1%	+$31.5K	0.02%	337
2026 Q1	$2.53M	Buy	5,705 +218	+4%	+$102K	0.03%	333
2025 Q4	$2.49M	Sell	5,487 -3,057	-36%	-$1.32M	0.02%	334
2025 Q3	$3.38M	Buy	8,544 +3,050	+56%	+$1.27M	0.04%	297
2025 Q2	$2.42M	Buy	5,494 +66	+1%	+$30.4K	0.03%	314
2025 Q1	$2.67M	Sell	5,428 -273	-5%	-$127K	0.04%	305
2024 Q4	$2.27M	Buy	5,701 +402	+8%	+$186K	0.03%	310
2024 Q3	$2.45M	Sell	5,299 -32,105	-86%	-$15.4M	0.03%	312
2024 Q2	$16.5M	Buy	37,404 +402	+1%	+$174K	0.27%	81
2024 Q1	$15.4M	Buy	+37,002	New	+$15.6M	0.25%	87

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Mediolanum International Funds's VRTX Position: Q2 2026 in Review

Mediolanum International Funds increased its Vertex Pharmaceuticals (VRTX) stake by 1.2% in Q2 2026, buying an estimated $31.5K and bringing the position to 5,776 shares worth $2.89M. The position accounts for 0.02% of the portfolio, ranked #337.

Mediolanum International Funds first reported a position in VRTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $16.5M in Q2 2024. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Mediolanum International Funds held 5,776 shares of Vertex Pharmaceuticals worth $2.89M as of Q2 2026.
Mediolanum International Funds bought 71 Vertex Pharmaceuticals shares in Q2 2026, an estimated $31.5K.
Vertex Pharmaceuticals made up 0.02% of Mediolanum International Funds's portfolio in Q2 2026, its #337 holding.
Mediolanum International Funds first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
Mediolanum International Funds's Vertex Pharmaceuticals position peaked at $16.5M in Q2 2024.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.